TLTsung-Ling Lee

Tsung-Ling Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tsung-Ling Lee has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating neuroprivacy concerns in human brain organoid research

    by Masanori Kataoka, Shu Ishida, Chie Kobayashi, Tsung-Ling Lee, Tsutomu Sawai


  • Open Access

    Human Brain Organoid Research and Applications: Where and How to Meet Legal Challenges?

    by M. Kataoka, T.-L. Lee, T. Sawai

    An ethical and legal framework is needed to regulate the rapidly developing human brain organoid research field properly. However, considering the legal issues involved in human brain organoid research remains underdeveloped and scattered. This article reviews the legal issues of human brain organoid research, grouping them into the following five broad themes: (1) consciousness, (2) legal status, (3) consent, (4) ownership, and (5) transplantation. The issues in each topic include both the urgent (e.g., appropriate forms of consent) and the speculative (e.g., protection of conscious human brain organoids). Therefore, we have attempted to be as explicit as possible about the timescale within which each issue will be realized and to prioritize each. Examining these issues has revealed legal issues specific to human brain organoid research and issues common to research in other fields. Further discussion of human brain organoid research from a legal perspective is needed in the future, considering discussions in related fields.


  • Open Access

    Navigating equity in global access to genome therapy expanding access to potentially transformative therapies and benefiting those in need requires global policy changes

    by Tsung-Ling Lee, Tsutomu Sawai

    In December 2023, the US Food and Drug Administration and the UK Medicines and Healthcare Products Regulatory Agency granted the first regulatory approval for genome therapy for sickle cell disease. This approval brings hope to those suffering from this debilitating genetic disease. However, several barriers may hinder global patient access, including high treatment costs, obtaining informed consent for minors, inadequate public health infrastructure, and insufficient regulatory oversight. These barriers reflect the structural inequalities inherent in global health governance, where patient access often depends on social and institutional arrangements. This article addresses concerns around informed consent, treatment costs, and patient access, and proposes corresponding policy reforms. We argue that these discussions should be framed within a broader global context that considers social and institutional structures, global research priorities, and a commitment to health equity.


  • Open Access

    Global governance of human brain organoid research and applications: A role for the World Health Organization?

    by Tsung-Ling Lee, Tsutomu Sawai

    Human brain organoid research and applications have generated considerable ethical discussions, yet as with other technologies, anticipating potential transnational issues associated with research and cross-border commercialization of organoids would allow a proactive approach as the field advances rapidly. This policy piece explores the potential role of the World Health Organization in the global governance of human brain organoid research applications by examining its legal authority and recent scientific activities in grounding foresight to harness the power of science to better global health.


  • Open Access

    Submission on the first draft general recommendation no. 37 (2023) on racial discrimination in the enjoyment of the right to health

    by Roojin Habibi, Matiangai V. S. Sirleaf, Judith Bueno de Mesquita, Gian Luca Burci, Stéphanie Dagron, Mark Eccleston-Turner, Luciano Bottini Filho, Lisa Forman, Sam Halabi, Tsung-Ling Lee, et al.

    This written submission was presented to the Committee on the Elimination of Racial Discrimination (CERD) on 4 August 2023. The submission comments on the first draft of CERD's general recommendation no. 37 on racial discrimination in the enjoyment of the right to health. The authors commend the Committee’s leadership and efforts in developing a general recommendation on the right to health, building on significant normative advancements on securing equality in the enjoyment of the right to health. However, the social, economic, and public health shockwaves caused by COVID-19 require more careful assessment and engagement by this general recommendation. Such an assessment is ever more necessary as the world is on the brink of adopting new international legal instruments that will shape how the international community responds to the next global health emergency. Moreover, the authors caution the Committee from adopting any recommendation or using any language that will reify a biological understanding of race, instead of emphasizing the social effects of racial discrimination and racism in health risks and public health outcomes.

  • Open Access

    The legal personhood of human brain organoids

    by Masanori Kataoka, Tsung-Ling Lee, Tsutomu Sawai

    Research using three-dimensional neural tissues derived from human pluripotent stem cells—known as ‘human brain organoids’—has progressed rapidly in recent years. Although related ethical issues have been intensively discussed, legal issues have only been sparsely examined compared with the related ethical issues. In this paper, we explore a fundamental issue concerning the legal status of human brain organoids: whether they can be considered legal persons. We clearly distinguish between two types of legal personhood: ‘natural person’ as a human legal person and ‘juridical person’ as a nonhuman legal person. By examining natural and juridical personhood separately, we point out the bias and confusion in the remarks on the legal personhood of human brain organoids and provide a more comprehensive picture of the problem.


  • Open Access

    The Rise of Technocracy and the COVID-19 Pandemic in Taiwan: Courts, Human Rights, and the Protection of Vulnerable Populations

    by Tsung-Ling Lee

    Driven by the need to address the immediate public health threats of the COVID-19 pandemic, this has seen a rise of the technocratic mode of governance around the world. A technocratic approach is evidence-based and relies upon the guidance of experts to respond to the public health crisis. The rise of technocracy reflects a utilitarian calculus that seeks to preserve the greater good. Taiwan’s pandemic response exemplifies the strengths and weaknesses of this type of governance. Based on an analysis of the relevant case law of the Taiwan Constitutional Court, legislation, and political developments this Article takes a legal-historical look and traces the current technocratic approach—defined for this Article as an experts-driven and procedural-driven process—which is a hallmark of Taiwan’s pandemic response. Examining Taiwan’s pandemic response through a human rights lens sheds light on a more complex relationship between the collective right to health and life, and the individual rights to health, work, privacy, and liberty during the pandemic.


  • Open Access

    COVID-19 Vaccination Certificates and Their Geopolitical Discontents

    by Tsung-Ling Lee

    At the international level, proof of vaccination against SARS-CoV-2 offers an enticing promise to the return of normality, particularly for the much-desired reopening of national borders. At the same time, vaccination passports could be a false hope: the requirement of vaccine passports could adversely embed social and economic inequalities that reflect the power dynamics in international relations. Specifically, the ability to secure vaccines relates to the varying market and economic power across countries. This paper focuses on Taiwan as a case study to explore ways in which the use of COVID-19 certifications, if used as a precondition for international travel, would further exacerbate a binary of exclusion and inclusion as a function of geopolitics. With its relative success in containing the COVID-19 pandemic within its borders, Taiwan represents a low priority for vaccine distribution in the COVAX initiative. Furthermore, due to Taiwan’s contentious political status and its exclusion from the World Health Organization regime, if vaccination passports are required as a precondition for international travel, then outbound passengers from Taiwan potentially could be subjected to restriction of movement absent wide availability of vaccines domestically. This paper argues that insofar as sustainable pandemic control requires a global concerted effort, vaccination passports could further polarise a global response. This paper suggests that equitable access to effective vaccines worldwide and governance reform of global health would help to rebuild global solidarity and mitigate the unimaginable human, social and economic suffering arising from the pandemic.


  • Mapping the Ethical Issues of Brain Organoid Research and Application

    by Tsutomu Sawai, Yoshiyuki Hayashi, Takuya Niikawa, Joshua Shepherd, Elizabeth Thomas, Tsung-Ling Lee, Alexandre Erler, Momoko Watanabe, Hideya Sakaguchi

    In 2008, researchers created human three-dimensional neural tissue – known as the pioneering work of “brain organoids.” In recent years, some researchers have transplanted human brain organoids into animal brains for applicational purposes. With these experiments have come many ethical concerns. It is thus an urgent task to clarify what is ethically permissible and impermissible in brain organoid research. This paper seeks (1) to sort out the ethical issues related to brain organoid research and application and (2) to propose future directions for additional ethical consideration and policy debates in the field. Toward (1), this paper first outlines the current state of brain organoid research, and then briefly responds to previously raised related ethical concerns. Looking next at anticipated scientific developments in brain organoid research, we will discuss (i) ethical issues related to in vitro brain organoids, (ii) ethical issues raised when brain organoids form complexes or have relationships with other entities, and (iii) ethical issues of research ethics and governance. Finally, in pursuit of (2), we propose research policies that are mindful of the ethics of brain organoid research and application and also suggest the need for an international framework for research and application of brain organoids.